Synthesis and antibacterial evaluation of novel hydrophilic ocotillol-type triterpenoid derivatives from 20(S)-protopanaxadiol

Records of Natural Products

Volumn 9, Issue 3, 2015, Pages 356-368

  Bi, Yi ^a   Ma, Cong ^b   Zhou, Zhiwen ^c   Zhang, Tingting ^a,d   Zhang, Hengyuan ^c   Zhang, Xiaochen ^a   Lu, Jing ^a   Meng, Qingguo ^a   Lewis, Peter J ^b   Xu, Jinyi ^c  

^a YANTAI UNIVERSITY   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c China Pharmaceutical University   (China)

^d GUANGXI NORMAL UNIVERSITY   (China)

Author keywords

Antibacterial activity; Ocotillol; Synergistic effect; Triterpenoid

Indexed keywords

CHLORAMPHENICOL; EPOXY 3 OXIME DAMMARANE 12BETA,25 DIOL 3 ONE; EPOXY 3BETA O (2 AMINOACETYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O (3 CARBOXYPROPIONYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O (4 CARBOXYBUTYRYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O (4 PIPERIDINE FORMYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O (DIENE ADIPOYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O (ENE BUTYRYL)DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O ACETYL DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O ACRYLOYL DAMMARANE 12BETA,25 DIOL; EPOXY 3BETA O OCTANOYL DAMMARANE 12BETA,25 DIOL; EPOXY DAMMARANE 12BETA,25 DIOL 3 ONE; EPOXY DAMMARANE 3BETA,12BETA,25 TRIOL; KANAMYCIN; PROTOPANAXADIOL; TRITERPENOID; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; HYDROPHILICITY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84928118270     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. J. Davies and D. Davies (2010). Origins and Evolution of Antibiotic Resistance, Microbio. Mol. Biol. Rev. 74, 417-433.
2. H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheld, B. Spellberg and J. Bartlett (2009). Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America, Clin. Infect. Dis. 48, 1-12.
3. L. Cantas, S. Q. A. Shah, L. M. Cavaco, C. M. Manala, F. Walsh, M. Popowska, H. Garelick and H. Burgmann (2013). A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota, Front. Microbiol. 4, 96-96.
4. C. Walsh (2003). Where will new antibiotics come from? Nat Rev Microbiol. 1, 65-70.
5. R. A. Hill and J. D. Connolly (2012). Triterpenoids, Nat. Prod. Rep. 29, 780-818.
6. M. Saleem, M. Nazir, M. S. Ali, H. Hussain, Y. S. Lee, N. Riaz and A. Jabbar (2010). Antimicrobial natural products: an update on future antibiotic drug candidates, Nat. Prod. Rep. 27, 238-254.
7. A. Jimenez-Arellanes, M. Meckets, J. Torres and J. Luna-Herrera (2007). Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae), J. Ethnopharmacol. 111, 202-205.
8. U. V. Mallavadhani, A. Mahapatra, K. Jamil and P. S. Reddy (2004). Antimicrobial Activity of Some Pentacyclic Triterpenes and Their Synthesized 3-O-Lipophilic Chains, Biol. Pharmaceut. Bull. 27, 1576-1579.
9. L. de Leon, B. Beltran and L. Moujir (2005). Antimicrobial Activity of 6-Oxophenolic Triterpenoids Mode of Action against Bacillus subtilis, Planta. Med. 71, 313-319.
10. D. R. Katerere, A. I. Gery, R. J. Nash and R. D. Waigh (2003). Antimicrobial activity of pentacyclic triterpenes isolated from African Combretaceae, Phytochemistry. 63, 81-88.
11. H. Haraguchi, S. Kataoka, S. Okamoto, M. Hanafi and K. Shibata (1999). Antimicrobial triterpenes from Ilex integra and the mechanism of antifungal action, Phytother. Res. 13, 151-156.
12. J. Liu (1995). Pharmacology of oleanolic acid and ursolic acid, J. Ethnopharm. 49, 57-68.
13. M. F. Melzig, G. Bader and R. Loose (2001). Investigations of the Mechanism of Membrane Activity of Selected Triterpenoid Saponins, Planta. Med. 67, 43-48.
14. E. W. Warnhoff and C. M. M. Halls (1965). Desert Plant Constituents: II. Ocotillol: an Intermediate in the Oxidation of Hydroxy Isooctenyl Side Chains, Can. J. Chem. 43, 3311-3321.
15. Z. Zhou, C. Ma, H. Zhang, Y. Bi, X. Chen, H. Tian, X. Xie, Q. Meng, P. J. Lewis and J. Xu (2013). Synthesis and Biological Evaluation of Novel Ocotillol-Type Triterpenoid Derivatives as Antibacterial Agents, Eur. J. Med. Chem. 68, 444-453.
16. Y. Bi, C. Ma, H. Zhang, Z. Zhou, J. Yang, Z. Zhang, Q. Meng, P. J. Lewis and J. Xu (2014). Novel 3-substituted ocotillol-type triterpenoid derivatives as antibacterial candidates. Chem. Biol. Drug Des. 84, 489-496.
17. C. Ma, X. Yang, H. Kandemir, M. Mielczarek, E. B. Johnston, R. Griffith, N. Kumar and P. J. Lewis (2013). Inhibitors of Bacterial Transcription Initiation Complex Formation, ACS. Chem. Biol. 8, 1972-1980.
18. B. C. Chan, M. Ip, H. Gong, S. L. Lui, R. H. See, C. Jolivalt, K. P. Fung, P. C. Leung, N. E. Reiner and Lau (2013). Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/UL5054 and inhibition of MRSA pyruvate kinase, Phytomedicine. 20, 611-614.
19. A. H. Delcour (2009). Outer Membrane Permeability and Antibiotic Resistance, Biochim. Biophys. Acta. 1794, 808-816.
20. P. G. Mortimer and L. J. Piddock (1993). The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli, J. Antimicrob. Chemother. 32, 195-213.